Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate desmoteplase (which is a manufactured protein
derived from the saliva of the vampire bat) in dissolving clots that are blocking the flow of
blood through one (or more) of the blood vessels supplying the brain, thereby reopening the
blocked blood vessel and allowing blood to flow again in individuals suffering from ischemic
stroke.